ClearPoint Neuro, Inc. Share Price & Technical Analysis
CLPT · $11.44 (-2.22%)
Healthcare / Medical Devices
$11.44
-2.22%
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which c…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -16% avg return in past 3 year May month.
5% return in 2026, 60% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | -2% | -8% | 22% | 0% | – | – | – | – | – | – | – | 5% |
| 25 | 12% | -15% | -19% | 18% | -19% | 1% | -13% | 4% | 112% | 7% | -12% | -3% | 74% |
| 24 | 4% | -9% | 6% | -21% | -4% | -2% | 33% | 81% | -12% | 10% | -2% | 23% | 109% |
| 23 | 10% | -10% | 0% | 24% | -27% | -5% | 0% | -16% | -14% | 10% | 5% | 17% | -5% |
| 22 | -23% | -1% | 20% | -17% | 28% | 18% | 10% | -9% | -17% | -6% | -9% | -11% | -18% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$370.78M
P/E ratio
—
52W high
$30.10
52W low
$8.27
Volume
4,52,234
Beta
1.29
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ClearPoint Neuro, Inc. share price today?
- ClearPoint Neuro, Inc. (CLPT) last traded around $11.44 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CLPT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CLPT. Download the app for real-time alerts.
- How can I analyze ClearPoint Neuro, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.